CompletedNCT00368849
Atomoxetine for attention and movement in Huntington disease
About this title
Read the official source — NCT00368849Medication studyAges 18–65United StatesADHD
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Iowa CitySee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateNovember 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 20
- Sponsor
- University of Iowa
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00368849
- Official title
Show the full official title
Atomoxetine for Attention Deficits in Adults With Mild HD: A Randomized, Placebo-Controlled Crossover Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Iowa City
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Iowa, a university.
Did this study involve medication?
Yes. The study involved medication, including atomoxetine and Matching Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
